JUPITER, Fla., Aug. 5, 2014 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), a global biotechnology company whose patented and proprietary technologies are used to develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today that it has signed a collaboration agreement to commercialize second generation biofuel and bio-based chemical technology with Compagnie Industrielle de la Matiere Vegetale ("CIMV"), a pioneer in developing processes for the production of biofuels and bio-based chemicals.
CIMV's patented approach of separating the three main components of plant material allows both production of high quality cellulose and hemicellulose, especially well-suited for the enzymatic process, and Biolignin™, a pure form of lignin that may be sold commercially as a high value, environmentally friendly alternative to petroleum-derived chemicals. The technology has garnered industry acclaim in winning the Pierre Potier Prize for Innovation in Chemistry and Frost & Sullivan's 2013 French Visionary Innovation Award.
Under the collaboration agreement, Dyadic and CIMV will work together to develop more efficient, fully integrated processes to produce environmentally low impact biofuels and bio-based chemicals. Dyadic anticipates supplying enzymes to CIMV's planned 2015 demonstration plant, as well as, licensing its C1 technology for on-site production of enzymes at CIMV's future commercial scale plants.
To complete the value chain from biomass to bioethanol, CIMV is also collaborating with Taurus Energy AB, a leading developer of yeast technology to turn cellulosic sugar into bioethanol, and for its international development with Pierson Capital, a lea
|SOURCE Dyadic International, Inc.|
Copyright©2014 PR Newswire.
All rights reserved